Tipepidine
- Generic Name
- Tipepidine
- Drug Type
- Small Molecule
- Chemical Formula
- C15H17NS2
- CAS Number
- 5169-78-8
- Unique Ingredient Identifier
- 2260ZP67IT
Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial
Phase 1
Completed
- Conditions
- Attention Deficit Disorder With Hyperactivity DiseaseAttention Deficit and Disruptive Behavior DisordersHyperkinesis
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-12-02
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Chiba University
- Target Recruit Count
- 21
- Registration Number
- NCT02305134
- Locations
- 🇯🇵
Department of Psychiatry, Chiba University School of Medicine, Chiba, Chuo-ku, Japan
An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2014-05-23
- Lead Sponsor
- Chiba University
- Target Recruit Count
- 10
- Registration Number
- NCT01835847
- Locations
- 🇯🇵
Department of Psychiatry, Chiba University School of Medicine, Chiba, Chuo-ku, Japan
An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2
Completed
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Interventions
- First Posted Date
- 2013-04-18
- Last Posted Date
- 2014-02-21
- Lead Sponsor
- Chiba University
- Target Recruit Count
- 10
- Registration Number
- NCT01835093
- Locations
- 🇯🇵
Department of Psychiatry, Chiba University School of Medicine, Chiba, Chuo-ku, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath